Why the NIH Trial to Assess Chelation Therapy (TACT) should be abandoned
about
Targeted chelation therapy with EDTA-loaded albumin nanoparticles regresses arterial calcification without causing systemic side effects.Chelation: harnessing and enhancing heavy metal detoxification--a reviewClawing back: broadening the notion of metal chelators in medicineEfficacy of reversal of aortic calcification by chelating agentsSynthesis and Crystal Structure of the Bioinorganic Complex [Sb(Hedta)]·2H2O.Fatalities after CAM: an overview.
P2860
Why the NIH Trial to Assess Chelation Therapy (TACT) should be abandoned
description
2008 nî lūn-bûn
@nan
2008 թուականին հրատարակուած գիտական յօդուած
@hyw
2008 թվականին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Why the NIH Trial to Assess Chelation Therapy (TACT) should be abandoned
@ast
Why the NIH Trial to Assess Chelation Therapy (TACT) should be abandoned
@en
Why the NIH Trial to Assess Chelation Therapy (TACT) should be abandoned
@nl
type
label
Why the NIH Trial to Assess Chelation Therapy (TACT) should be abandoned
@ast
Why the NIH Trial to Assess Chelation Therapy (TACT) should be abandoned
@en
Why the NIH Trial to Assess Chelation Therapy (TACT) should be abandoned
@nl
prefLabel
Why the NIH Trial to Assess Chelation Therapy (TACT) should be abandoned
@ast
Why the NIH Trial to Assess Chelation Therapy (TACT) should be abandoned
@en
Why the NIH Trial to Assess Chelation Therapy (TACT) should be abandoned
@nl
P2093
P2860
P1476
Why the NIH Trial to Assess Chelation Therapy (TACT) should be abandoned
@en
P2093
Elizabeth Woeckner
Kimball C Atwood
Robert S Baratz
Wallace I Sampson
P2860
P407
P577
2008-01-01T00:00:00Z